Pulmonary Embolism After Liver Resection

December 5, 2011 updated by: Emmanuel Melloul, Beaujon Hospital

Pulmonary Embolism After Liver Resection: A Prospective Analysis of Risk Factors

Major surgery is associated with a postoperative hypercoagulable state related to the surgical trauma that may lead to thromboembolic complications. To the investigators knowledge, only two series have reported the risk of PE after liver surgery with an incidence of up to 6.3% The purpose of this study is to identify the independent risk factors associated with the development of PE after elective liver surgery.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Clichy
      • Paris, Clichy, France, 92110
        • Prof. Jacques Belghiti

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All consecutive patients that will undergo liver resection for any type of liver disease.

Description

Inclusion Criteria:

  • Age >18 years
  • Malignant liver diseases
  • Benign liver diseases

Exclusion Criteria:

  • Age <18 years
  • Previous history of thromboembolic events
  • Living Donor hepatectomies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Liver resection patients
All patients that underwent elective liver resection for both malignant and benign diseases.
Hepatectomy including both minor and major.
Other Names:
  • Hepatectomy, liver resection
Computed Tomography +/- pulmonary angiography
Other Names:
  • CT, CTPA, CT-PA, MSCT, MSCT-PA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulmonary embolism
Time Frame: up to January 2012
Blood clots in the lungs that may lead to sudden death.
up to January 2012

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: up to January 2012
Any type of post-operative complications graded according to the Clavien-Dindo Classification of Surgical Complications
up to January 2012
Length of hospital stay
Time Frame: up to January 2012
The duration of hospitalization in days.
up to January 2012
Mortality
Time Frame: up to January 2012
Post-operative 90-Day Mortality
up to January 2012

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jacques Belghiti, MD, Beaujon Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2007

Primary Completion (Anticipated)

January 1, 2012

Study Completion (Anticipated)

January 1, 2012

Study Registration Dates

First Submitted

December 4, 2011

First Submitted That Met QC Criteria

December 5, 2011

First Posted (Estimate)

December 6, 2011

Study Record Updates

Last Update Posted (Estimate)

December 6, 2011

Last Update Submitted That Met QC Criteria

December 5, 2011

Last Verified

December 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Death

Clinical Trials on Liver resection

3
Subscribe